Refine Your Face (O/W Gel) MDA-S-65-16

Merck KGaA
Phase
Product
INCI Name
Supplier
Volume
A
Eusolex® UV-Pearls® OB-S
AQUA (WATER), OCTOCRYLENE, SORBITOL, BUTYL METHOXYDIBENZOYLMETHANE, SILICA, PVP, CHLORPHENESIN, PHENOXYETHANOL, DISODIUM EDTA
1
15.00
RonaFlair® White Sapphire
SYNTHETIC SAPPHIRE
1
3.00
1.3-Butanediol
BUTYLENE GLYCOL
1
3.00
Water, demineralized
ad 100
B
RonaCare® AP
BIS-ETHYLHEXYL HYDROXYDIMETHOXY BENZYLMALONATE
1
0.50
Sepinov P88
SODIUM ACRYLATE, ACRYLOYL DIMETHYLTAURATE, DIMETHYLACRYLAMIDE CROSSPOLYMER
2
2.00
Miglyol 812 N
CAPRYLIC/CAPRIC TRIGLYCERIDE
3
3.00
Cetiol CC
DICAPRYLYL CARBONATE
4
2.50
Xiameter® PMX-0345
CYCLOPENTASILOXANE, CYCLOHEXASILOXANE
5
2.00
Xiameter® PMX-200 (100cs)
DIMETHICONE
5
1.00
C
RonaCare® Cyclopeptide-5
AQUA (WATER), ALCOHOL DENAT., LECITHIN, ECTOIN,CYCLOTETRAPEPTIDE-24 AMINOCYCLOHEXANE CARBOXYLATE
1
2.00
Preservatives
qs

Preparation:

Add phase A slowly with vigorous stirring to phase B. Homogenize. Afterwards add phase C.

Notes:

pH (24°C) = 5.6Viscosity: 50000 cps (Brookfield DV- II+, Helipath spindle C, 10 rpm) at 24°C (1) Merck KGaA, Darmstadt, Germany / EMD Chemicals (2) Seppic GmbH (3) Sasol Germany GmbH (4) BASF AG (5) Dow Corning
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

Connex-C Asia 2025

Lee Kong Chian School of Medicine - Ong Tiong Tat and Irene Tan Liang Kheng Auditorium 11 Mandalay Road, Level 4, Singapore 308232
31 July - 1 August 2025

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025